Advisory Services Network’s Denali Therapeutics DNLI Stock Holding History

Advisory Services Network’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-848	Closed	-$16.3K	–	2803
2026 Q1	$16.3K	Buy	+848	New	+$16.9K	﹤0.01%	3306
2025 Q4	–	Sell	-39	Closed	-$566	–	2441
2025 Q3	$566	Buy	+39	New	+$560	﹤0.01%	4029
2024 Q1	–	Sell	-309	Closed	-$6.63K	–	2000
2023 Q4	$6.63K	Buy	+309	New	+$6.12K	﹤0.01%	3014
2023 Q2	–	Sell	-300	Closed	-$6.91K	–	1999
2023 Q1	$6.91K	Hold	300	–	–	﹤0.01%	3021
2022 Q4	$8.34K	Buy	+300	New	+$8.93K	﹤0.01%	2927
2021 Q3	–	Sell	-1,922	Closed	-$151K	–	1856
2021 Q2	$151K	Sell	1,922 -1,717	-47%	-$106K	﹤0.01%	1395
2021 Q1	$208K	Sell	3,639 -2,071	-36%	-$139K	0.01%	1166
2020 Q4	$478K	Buy	5,710 +91	+2%	+$5.5K	0.02%	756
2020 Q3	$201K	Buy	+5,619	New	+$169K	0.01%	968
2020 Q2	–	Sell	-5,246	Closed	-$92K	–	1430
2020 Q1	$92K	Buy	+5,246	New	+$109K	0.01%	1102

Other funds holding DNLI

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's DNLI Position: Q2 2026 in Review

Advisory Services Network sold out of Denali Therapeutics (DNLI) in Q2 2026, closing a stake of 848 shares — an estimated $16.3K sold.

Advisory Services Network first reported a position in DNLI in Q1 2020 and held it in 10 quarters. The position peaked at $478K in Q4 2020. 292 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

Advisory Services Network reported no remaining Denali Therapeutics position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 848 Denali Therapeutics shares in Q2 2026, an estimated $16.3K.
Advisory Services Network first reported a position in Denali Therapeutics in Q1 2020 and held it in 10 quarters.
Advisory Services Network's Denali Therapeutics position peaked at $478K in Q4 2020.
292 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.